We are building the field infrastructure that turns isolated excellence
into transparent, verifiable standards for psychedelic practice.
Co-designed with experts across research, harm reduction,
and clinical and non-clinical practice.
Excellent psychedelic practice is complex. It draws on ethics, competence, safety, setting, preparation, integration, legal awareness, and the ability to work responsibly with people in vulnerable moments.
PsyStandard turns that complexity into a living verification framework —
co-designed with academic institutions, harm reduction experts, and
practitioner communities, and tested in practice.
Two parts, one system. The standard defines good practice. Membership
is how practitioners meet it and uphold it
What good practice is measured against
An evidence-based, multi-layer assessment of demonstrated competence — from credentials to observed practice. Published in full, co-designed with the field.
Explore the standard
How practitioners meet it, and stay accountable
Verified practitioners join a professional community with named supervision, continuing development, peer accountability, and a code of ethics.
Explore membership
Being involved in clinical research with psychedelics, it is clear how important it is to develop rigorous, ethical and safe standards for those interested in working with these powerful compounds. PsyStandard provides a valuable framework for ensuring this work is conducted to the highest scientific standards, supporting safe and beneficial outcomes for all involved.
Through my work in mental health care, I’ve come to see how essential credible and recognisable standards are — particularly for start-ups in emerging fields. PsyStandard is uniquely placed to create that difference for all stakeholders and it is great to contribute to this.
It is an absolute privilege to join PsyStandard and to work alongside leading experts on raising standards and accountability across this field — spanning prescribers, pharmacies, therapists, and the wider community of practitioners. I’m excited to be part of building something the field can trust.
In a field where most practitioners work alone, unregulated, and with clients who are in a substantial and suggestible altered state of consciousness, psychedelic intervision, or ongoing peer-to-peer reflection, is closer to essential infrastructure than a simple nice-to-have. Ultimately, however sound one’s own therapeutic perspective, framework or positionality, neither you nor your clients may be […]
Neurodivergent people are already in psychedelic spaces. Diagnosed or not, disclosed or not – they are already showing up to ceremonies, clinical trials, and coaching sessions. The question is whether the space is ready for them. Guest contributions from Dr. WaiFung Tsang and Nadia Violet Erlam Foreword By Dr. WaiFung Tsang Neurodiversity should not be […]
I spend much of my working life inside psychedelic clinical studies. From the outside, a psychedelic study may look, at this point in time, given the 200+ clinical trials globally and an even greater number of experimental medicine studies, a relatively simple and easy thing to deliver and do. A person receives a drug, has […]
The morning of the ceremony, I wake with abdominal pain. I am on day 38 of my cycle. My period normally arrives around day 30 or 31, but something has been shifting in recent months. My cycles are getting longer, and my period keeps arriving later. A few hours later, I am lying on a […]
The couple in the room More couples are seeking psychedelic support together, and they arrive through different doors. Some come after one partner’s individual journey shifted something between them. Some arrive carrying a specific wound, a break in trust and agreement, a loss, and ask for repair before anything else. Many begin with conflict work […]
FOREWORD Psychedelic research is often framed around a simple question: do these treatments work? Over the past decade, that question has generated an exciting body of research. But as psychedelic-assisted therapy moves closer to clinical implementation, I think another question is becoming just as important: what actually determines whether someone benefits? In my PhD research, […]
Some of the most important experiences a client brings back are the ones no one taught their practitioner how to hold. A being that seemed to communicate, sense of having touched something sacred, the conviction that they briefly saw how everything connects. In almost every conversation we have about experiences like these, the same thing comes up: the person was left alone with the part that mattered most.
PsyStandard, a Pink Elephant Company, and Drug Science announce a co-design partnership to develop the clinical and ethical foundations of PsyStandard’s European practitioner verification framework. The partnership addresses a structural gap in how practitioner quality is assessed in psychedelic practice. People seeking support — whether through clinical therapy, retreat settings, or integration coaching — currently […]
Non-clinical and clinical practitioners alike — coaches, facilitators, integration specialists, therapists. If you take this work seriously, it’s for you.
A listing is self-declared. Verification is assessed — credential review, a structured call, and observed practice, scored against published criteria.
Verified practitioners join PsyStandard membership — ongoing supervision, peer accountability, and annual review keep the badge valid.
We are assembling the first practitioners to be verified under the framework and to help shape it. Apply to be part of it.
PsyStandard Community, guided by trusted experts in mental health and wellbeing. Learn from others, share your journey, ask anonymously, and get evidence-based answers. Real stories, real support, zero judgment
Tell us who you are, and we’ll make sure you get the right updates when the directory launches.
We’re assembling the first practitioners to be verified under the framework.
Tell us a bit about your practice.
